Poland· PL-100412886

Soledum forte

A cineole product containing cineolum, registered in Poland by M.C.M. Klosterfrau Healthcare Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.

ATC R05CA13

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedSoledum forteATCR05CA13REGISTER NO.PL-100412886PACKS LISTED3CHECKEDSeptember 27, 2026

Where it is registered

Cineole is registered in 4 of 19 countries.

Countries holding a registration under ATC R05CA13 (cineole), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose

Cineole · ATC R05CA13

4 / 19 countries

  • Czechiaprice
  • Germany
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Cineolum
Manufacturer
M.C.M. Klosterfrau Healthcare Sp. z o.o.
Country
Poland (PL)
ATC code
R05CA13
ATC class
Cineole
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991409807
  • gtin
    05909991409814
  • gtin
    05909991409821

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cineole in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cineole products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Austria · Cinolpro, Cinolpro Forte
  • Czechia · Soledum
  • Germany · Cineol, Cinolpro
  • Hungary · Soledum
  • Romania · Soledum
  • Slovenia · Soledum
  • Slovakia · Soledum

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c8b18ce3-bdd7-4c5f-9e64-45e96b385b7d
GET /v1/drugs/c8b18ce3-bdd7-4c5f-9e64-45e96b385b7d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki dojelitowe miękkie",
  "source": "urpl",
  "strength": "200 mg",
  "packaging": "05909991409807 ¦ OTC ¦ 133439\n20 kaps.\n05909991409814 ¦ OTC ¦ 133440\n50 kaps.\n05909991409821 ¦ OTC ¦ 133441\n100 kaps.",
  "substance": "Cineolum 200 mg",
  "common_name": "Cineolum",
  "pl_product_id": "100412886",
  "pozwolenie_nr": "25445",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about cineole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.